Top Markets
Coin of the day
Lobe Sciences Ltd. Lobe Sciences Ltd.

Lobe Sciences Ltd.

LOBE
Rangering i aksjer #30765
Lobe Sciences Ltd. operates as a life sciences entity, primarily focused on the... Lobe Sciences Ltd. operates as a life sciences entity, primarily focused on the exploration and advancement of psychedelic pharmaceutical compounds. The company is actively engaged in formulating psilocybin-derived therapeutics, combined with N-acetylcysteine, intended for the treatment of mild traumatic brain injuries and post-traumatic stress disorder. Beyond drug development, it also engineers specialized devices designed to facilitate the efficient delivery of various medications. The organization was previously known as Greenstar Biosciences Corp. before formally changing its name to Lobe Sciences Ltd. in November 2020. Its main corporate office is situated in Vancouver, Canada.
Aksjekurs
$0.05504527
Sist synkronisert: 2026-08-17
Markedsverdi
$15.64M
Endring (1 dag)
0.00%
Endring (1 år)
51.92%
Land
CA
Handel Lobe Sciences Ltd. (LOBE)

Kategori

P/B-forhold for Lobe Sciences Ltd. (LOBE)
P/B-forhold per 2026 TTM: 0
Ifølge Lobe Sciences Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Lobe Sciences Ltd. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter